Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent litigation
Pharma
Sandoz wins FDA nods for first Prolia, Xgeva biosimilars
Biosimilars to Amgen’s lucrative bone drugs Prolia and Xgeva triumphed at the FDA, though ongoing patent litigation makes the launch timing uncertain.
Fraiser Kansteiner
Mar 6, 2024 9:52am
Biogen notches another Tecfidera patent win in Europe
Dec 19, 2023 9:30am
AbbVie files patent litigation against generic Rinvoq makers
Nov 22, 2023 9:04am
FTC takes patent scrutiny to Sanofi, Mylan's insulin case
Nov 21, 2023 11:34am
Roche, Biogen settle Actemra biosimilar lawsuit
Oct 25, 2023 10:20am
CureVac touts 'progress' in vaccine patent case against BioNTech
Sep 28, 2023 2:45pm